Amalgamated Bank’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24K | Hold |
1,218
| – | – | ﹤0.01% | 2044 |
|
|
2025
Q1 | $24K | Hold |
1,218
| – | – | ﹤0.01% | 1996 |
|
|
2024
Q4 | $27K | Hold |
1,218
| – | – | ﹤0.01% | 2008 |
|
|
2024
Q3 | $31K | Hold |
1,218
| – | – | ﹤0.01% | 1983 |
|
|
2024
Q2 | $28K | Buy |
1,218
+431
| +55% | +$9.91K | ﹤0.01% | 2006 |
|
|
2024
Q1 | $14K | Sell |
787
-1,249
| -61% | -$22.2K | ﹤0.01% | 2284 |
|
|
2023
Q4 | $28K | Sell |
2,036
-234
| -10% | -$3.22K | ﹤0.01% | 2495 |
|
|
2023
Q3 | $31K | Hold |
2,270
| – | – | ﹤0.01% | 2453 |
|
|
2023
Q2 | $46K | Buy |
+2,270
| New | +$46K | ﹤0.01% | 2354 |
|